INFECT – an INterface For Empirical antimicrobial ChemoTherapy

The INFECT Project, initiated by the INFECT Association, aims to support healthcare professionals in treating patients with infectious diseases by providing intuitive access to combined data on local antimicrobial resistance, pathogens and antibiotics. INFECT AMR is a web application that imports anonymised patient susceptibility data, combines it with pathogen and antibiotics data, and shows it in a substance-by-organism matrix, which users can filter according to various parameters.

The INFECT AMR Processor, a distributed real-time in-memory analytics engine, manages the computational load. Users can filter data based on microbial, antimicrobial, or population attributes. Susceptibility is represented as a coloured circle, and pathogens with relevant susceptibility only at increased exposure and expected resistant or susceptible phenotypes are marked interactively.

The adaptable design of INFECT AMR permits adjustments to other data sources and the addition of supplementary modules. To broaden access and support antimicrobial stewardship in a multitude of settings, the INFECT Association has developed a web-based integrator platform, available at integration.infect.info, which allows institutions and organisations to incorporate a partial INFECT AMR resistance matrix as a predefined interactive widget in their web-based medical treatment guidelines or digital documents.

Planned and Upcoming Features

Detailed Resistance Data Including MIC Distribution

Benefit from a more comprehensive understanding of antimicrobial resistance patterns with our upcoming feature that includes detailed resistance data alongside MIC (Minimum Inhibitory Concentration) distribution. The MIC is a quantitative measure that represents the lowest concentration of an antimicrobial agent required to inhibit the visible growth of a microorganism in vitro. This metric helps healthcare professionals understand the susceptibility of a specific microorganism to different antimicrobial agents and aids in selecting appropriate treatments.

View of the INFECT AMR Matrix with the details panel open

Guideline Module as a Widget

The forthcoming guideline module widget promises seamless integration of third party evidence-based antimicrobial treatment recommendations into existing platforms, starting with the INFECT 3.0 application. This user-friendly addition will facilitate quick access to crucial guideline information, streamlining workflows and improving patient care by ensuring that up-to-date treatment guidance is always within reach. Standardised APIs to the widget may also support antimicrobial stewardship automation in the future.

View of the INFECT AMR Matrix with the guidelines panel open

INFECT Guidelines Framework with Widget Configurator and Structured Data Support

Anticipate a transformative approach to treatment guidelines with our innovative INFECT guidelines framework. This groundbreaking feature includes a widget configurator, allowing for customisation that meets your specific needs. Furthermore, it incorporates structured data support to ensure seamless integration and compatibility with various information systems, further enhancing the value of our platform.

Standardised APIs for Integration of INFECT AMR and Guidelines Framework

Prepare for effortless integration of INFECT AMR and the INFECT Guidelines framework into modern healthcare management systems using our new standardised APIs. Designed with interoperability in mind, these APIs will facilitate seamless communication between systems, enabling healthcare providers to access critical information, optimise workflows, and ultimately deliver better patient outcomes through data-driven decision-making.

Deploy INFECT AMR in your country

INFECT AMR: Innovating the Fight Against Antimicrobial Resistance

Discover the Future of Antimicrobial Stewardship with INFECT - A SaaS Solution to Combat Antimicrobial Resistance

INFECT AMR as a Service

INFECT AMR is a tried and tested innovative application, which is also offered in a Software as a Service (SaaS) model designed to empower nations and public health institutions in their fight against antimicrobial resistance. By harnessing the power of advanced data analytics and intuitive design, INFECT AMR innovates the way countries can bring their AMR data to the clinicians for their everyday use, supporting them with responsible antibiotic use and building a sustainable healthcare system.

Key Features

Proven Success in Combating AMR

INFECT AMR has been successfully implemented in a pioneering country, demonstrating its effectiveness in combating the threat of antimicrobial resistance. The results have been remarkable, paving the way for broader adoption and paving the way for a future where AMR is effectively managed.

Get Started with INFECT AMR Today

Join the revolution in antimicrobial stewardship and safeguard the future of medicine. Contact our team of experts to learn how INFECT can help your nation combat the global threat of antimicrobial resistance.

Please contact us at hello@infect.org for more information


INFECT – in collaboration with its partners – maintains this website to enhance public access to information about antibiotic resistance, treatment guidelines, antibiotic consumption, infection control and epidemiology. Our goal is to keep this information timely and accurate and to minimise disruption caused by technical errors. However, some data, information, content, or functions on our site may not be error-free and we cannot guarantee that our service will not be interrupted or otherwise affected by such problems.

Therefore, INFECT specifically DISCLAIMS LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES and assumes no responsibility or liability for any loss or damage suffered by any person as a result of the use or misuse of any of the information, content or function on this website or any linked external sites.

All information provided is:

Although INFECT is intended to be used to guide and support an optimal empirical antimicrobial therapy, its use does not substitute a thorough investigation of patients’ signs and symptoms, or sound diagnostic and therapeutic reasoning.